Dermata Therapeutics Inc. (DRMA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Dermata Therapeutics Inc.

    NASDAQ: DRMA · Real-Time Price · USD
    5.26
    -0.24 (-4.36%)
    At close: Sep 05, 2025, 3:59 PM
    5.35
    1.77%
    After-hours: Sep 05, 2025, 04:00 PM EDT

    Dermata Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -12.51M -8.04M -9.67M -7.86M
    Interest Income
    		 225.78K 247.22K n/a 45.61
    Pretax Income
    		 -12.29M -7.79M -9.61M -7.9M
    Net Income
    		 -12.29M -7.79M -9.61M -7.9M
    Selling & General & Admin
    		 4.31M 3.97M 4.02M 4.4M
    Research & Development
    		 8.2M 4.07M 5.65M 3.46M
    Other Expenses
    		 -242 n/a n/a n/a
    Operating Expenses
    		 12.51M 8.04M 9.67M 7.86M
    Interest Expense
    		 n/a n/a -63.57K 45.61K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 12.51M 8.04M 9.67M 7.86M
    Income Tax Expense
    		 n/a n/a -9.67K n/a
    Shares Outstanding (Basic)
    		 153K 19.4K 69.07K 52.05K
    Shares Outstanding (Diluted)
    		 153K 19.5K 69.07K 52.05K
    EPS (Basic)
    		 -80.32 -401.8 -139.2 -152.7
    EPS (Diluted)
    		 -80.32 -399.81 -139.2 -152.7
    EBITDA
    		 -12.29M 247.22K -9.61M -7.86M
    EBIT
    		 -12.29M -7.79M -9.61M -7.86M
    Depreciation & Amortization
    		 12.51M 8.04M 9.67M 322.00

    Add to Watchlist